Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	20836
Country	Germany

Received	2015-06-24 09:51
Peer-Review Started	2015-06-24 10:24
To Make the First Decision	2015-08-16 17:30
Return for Revision	2015-08-25 20:08
Revised	2015-09-22 15:23
Second Decision	2015-11-02 14:18
Accepted by Journal Editor-in-Chief	2015-11-02 15:35
Accepted by Company Editor-in-Chief	2015-11-11 18:00
Articles in Press	2015-11-11 18:00
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-01-11 19:53
Publish the Manuscript Online	2016-01-14 20:17

ISSN	1948-5204 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Review
Article Title	Multimodality treatment strategies have changed prognosis of peritoneal metastases
Manuscript Source	Invited Manuscript
All Author List	Corneliu Lungoci, Aurel Ion Mironiuc, Valentin Muntean, Traian Oniu, Hubert Leebmann, Max Mayr and Pompiliu Piso
Funding Agency and Grant Number
Corresponding Author	Dr. Pompiliu Piso, Professor of Surgery, Dr. Honoris Causa, Clinic of Visceral and General Surgery, Krankenhaus Barmherzige Brueder, Academic Teaching Hospitals of the University Regensburg, 86 Prufeninger Street, 93049 Regensburg, Bavaria Province, Germany. pompiliu.piso@barmherzige-regensburg.de
Key Words	Hyperthermic intraperitoneal chemotherapy; Peritonectomy procedures; Systemic chemotherapy; Peritoneal metastases; Survival
Core Tip	The multimodal treatment of peritoneal metastases (PM), involving cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, has been strenuously achieved over time, but seems to be the best treatment option, for selected cases. This paper addresses data about the multimodal treatment strategy, focused to patient’s survival, the key indicator for assessing results, in the case of PM. Also, it were highlighted the treatment key aspects and the controversies, high in the 35 years of treatment implementing. By understanding the philosophy of multimodal treatment, physicians will be able to offer an alternative to the routine systemic chemotherapy.
Publish Date	2016-01-14 20:17
Citation	Lungoci C, Mironiuc AI, Muntean V, Oniu T, Leebmann H, Mayr M, Piso P. Multimodality treatment strategies have changed prognosis of peritoneal metastases. World J Gastrointest Oncol 2016; 8(1): 67-82
URL	http://www.wjgnet.com/1948-5204/full/v8/i1/67.htm
DOI	http://dx.doi.org/10.4251/wjgo.v8.i1.67

Full Article (PDF)	WJGO-8-67.pdf
Full Article (Word)	WJGO-8-67.doc
Manuscript File	20836-Review.docx
Answering Reviewers	20836-Answering reviewers.pdf
Audio Core Tip	20836-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	20836-Conflict-of-interest statement.pdf
Copyright License Agreement	20836-Copyright assignment.pdf
Peer-review Report	20836-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	20836-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	20836-Scientific misconduct check.pdf
Scientific Editor Work List	20836-Scientific editor work list.pdf